Kidswell Bio Corporation (TYO:4584)
Japan · Delayed Price · Currency is JPY 245.00
-3.00 (-1.21%)
At close: Feb 6, 2026
Kidswell Bio Market Cap
Kidswell Bio has a market cap or net worth of 12.15 billion as of February 6, 2026. Its market cap has increased by 182.00% in one year.
Market Cap
12.15B
Enterprise Value
11.75B
Revenue
6.61B
Ranking
n/a
PE Ratio
39.56
Stock Price
245.00
Market Cap Chart
Since November 30, 2012, Kidswell Bio's market cap has increased from 2.73B to 12.15B, an increase of 344.60%. That is a compound annual growth rate of 11.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 12.30B | 22.17% |
| Dec 30, 2025 | 10.07B | 125.16% |
| Dec 30, 2024 | 4.47B | -11.75% |
| Dec 29, 2023 | 5.07B | -40.50% |
| Dec 30, 2022 | 8.52B | -45.05% |
| Dec 30, 2021 | 15.50B | 7.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemRIM | 17.80B |
| CanBas | 16.07B |
| ReproCELL | 15.43B |
| Immuno-Biological Laboratories | 14.53B |
| Kubota Pharmaceutical Holdings | 13.50B |
| Stella Pharma | 11.95B |
| CellSeed | 10.60B |
| Nano Holdings | 10.40B |